Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma

NCT07450040 · clinicaltrials.gov ↗
ENROLLING_BY_INVITATION
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Eye & ENT Hospital of Fudan University